Maud Bouvier, former alliance manager at Erytech Pharma, has been appointed vice president for business development at TxCell SA, the France-based cell therapy company. Dr Bouvier received her PhD in molecular biology from the Joseph Fourier University and a master’s degree in management from the Grenoble Management School, both in France.
Separately, Catherine Mathis previously a senior director at Voisin Consulting, has been appointed vice president for regulatory affairs. Ms Mathis’ business experience includes frequent interactions with drug regulators in the US and Europe as well as with health technology assessment bodies. Both appointments become effective on 1 January 2016.
Copyright 2015 Evernow Publishing Ltd